All good, brother. It’s entirely human to take personal

New Post Public Reply Private Reply Replies (3) Message Board
andyandred Evil Rabbit #68894
1,067
All good, brother. It’s entirely human to take personal ire to a public (or semi-public) forum these days. We live in an outrage culture online, and it’s better than taking it out on our family or friends. It’s healthy to vent. I guess my point is also just that it’s all tied to personal choices, and we are not victims here. I’ll bet if you had the foresight to sell all or a lot of your position on the $10 run-up in the summer (and I’m sure in hindsight you wish you had), and then you watched the share price plummet, you would feel like a genius and not so much like an idiot or a victim of shorts or NP or CytoDyn. You’d be excited to see the value of the company keep falling because you just made a ton of realized cash on this stock, and you want to buy back in with the house’s money at a lower or the lowest point. And then if you held off taking a position again till a few weeks ago when it hit $1.65 a share and you said to yourself: “this is the bottom, I getting my position back”, and the price then started to climb right after you bought back in, and it never sees that price ever again, all your foresight and tactical maneuvering would have made you feel very very differently about this stock and this company and its CEO these past 6 months. So your criticism of NP or dismay of the stock price drop, albeit certainly justified at times, isn’t entirely objective criticism nor is it really shared in service to the shareholder community; it’s just an emotional reaction to your stock portfolio and you need to point the finger away from yourself because you didn’t play sell/buy orders like a master trader. And I just believe that the mentality of accountability (not victimhood), and the underlying motivation of our communication is vital to not only the success of your communities, but also own personal growth and relationship with our own emotions and self-awareness. And when I’m “investing” in a company and product I believe as a result of rigorous due diligence, and I’m not just reading a stick to turn around some quick cash, then I try not to fret the stock volatility over any given day, week, month, or even year because it’s a long-term investment that I don’t worry about in that capacity; I may merely watch the share price when seeking opportunities to accumulate more shares in a dip or drop.

And when investors have an average share price of less than $1, which I assume you have if you have been critical of NP for over 3 years, I think it’s somewhat ungrateful to publicly complain about a company that has managed to get you in the black and keep you there for almost a year. I can appreciate it’s a vacillating scale, and it can be important to remain critical no matter the underlying financial circumstances, be it in the red or black (since evolution and growth of the company are the goal), but, from a data standpoint (using the share price as a measurement), there is more evidence to suggest our team is very good at what they do, and it’s wise to retain gratitude and perspective of that, especially when all the criticism is used more as emotional catharsis or blaming & shaming, and not as a constructive tool for the people we’re complaining about to grow from... we have their emails and can presents comments & questions on conference call - that is when the criticism is being used to try to improve and better understand the situation, and not just vent in a method that can poison the well in ways that only hurt the very thing you’re trying to protect & improve - the share price. And I think investors that post multiple times per day almost every day can lose perspective more easily, grow too obsessed, and they need to be able to step back entirely for weeks or longer, usually when negative emotions are running high, because if you don’t plan to buy or sell for a while, why bother to track and engage in something that is just causing stress and dismay? Regaining some objectivity and not getting too in the weeds with something we can’t ultimately control and we choose not to directly interface with the company management but merely comment in ways that they can’t see, that presents some warning signs that seasoned investors usually self-check and self-correct.

I can certainly come off like I’m lecturing, I get that. I just, at times, like to step in with some added perspective, which may sound judgmental or critical, but my tone can’t really be grasp in the written language as well as in voice, and my intent is to implore consistent posters, who often bash, to just ask how effective it is for the group, if it is serving their own investment, and is there more of an emotional/financial component that is driving the concern that wouldn’t be as strong or present if they were in a different position. Basically, it is being selfish or selfless by communicating that and in that way.

The interesting thing about investing in a company is that when we’re invested, we hate negative action on the stock price, but when we’re not and looking to get in or re-enter, we like the negative action and get nervous when the stock is going up and making in more expensive to get in or accumulate more. So I just think if investors truly believe in the science of this product, and the fact the company has rescued it from bankruptcy and got it to its most secure position to date, there is thus no need to risk putting cracks in the dams and publicly criticizing the company in ways that the company can’t use the feedback to grow. Call or email Nader when there’s issues; he’s accessible. And if the emotions are running too high and venting is necessary, and it needs to be done online among people who will get the context, then preface a public complaints with: I get this just me playing the victim right now because I’m mostly bummed my investment is down, and I do believe in this investment and I ultimately trust our leadership, but this is how I’m currently feeling and I need to say this ... (insert complaint / bash / criticism). Proper context and being accountable for our decisions and words is the truly healthy approach to investing, especially in investments with public online communities, and no one is forced to invest and no stock doesn’t fluctuate in value (just look a Tesla there last few years). And I do believe that victim mentalities don’t get rewarded, and they cause poor decisions to be made that one usually regrets if they become to pervasive and lead to actions being taken, so it’s wise to be mindful of when that mindset has taken hold and caused public outrage. I personally have very small CYDY groups over less than 10 people who have rules about confidentiality who we chat most openly with. That’s a safe and healthy environment to exercise the human emotions while not risking setting sell-offs from inexperienced and nervous investors who use online chatter from strangers to make their decisions, or triggering fodder for shorts to attack. I recommending starting a tight group you trust for those purposes, as these forums with 1000s of people are a dangerous place to get all uppity about our investment woes if you’re trying to protect the stock value.

Now that I’ve fed my proverbial horse, I’ll go walk my literal dog I’ll see all the resilient longs at the reunion in 2025 when we pull up to the private island in our yachts and we reminisce about all our online antics, and we also express our gratitude for a company that saved lives and made us rich in our bank accounts and our souls. GLTA.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omnicom Media: A Titan in Media Management Unveiled

Updated Category News Views 94

Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...

Continue Reading
FIS Slashes Forecast: Guidance Under Scrutiny Now

Updated Category News Views 21

Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 127

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
Community Rallies: FirstService Boosts Lurie Hospital

Updated Category News Views 83

Turning Connections into Contributions In Chicago, the 14th Annual IGC Vendor Expo wasn't just another corporate get-together. No, it was a gathering of FirstService Residential, their affiliates, and a whopping 92 In Good Company vendor participants, all united by a simple goal: to support Ann & Robert H. Lurie Children's Hospital. The result? A tidy $65,000 donation...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 52

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
TORM's Q3 Results Point to Strength Amid Global Chaos

Updated Category News Views 102

TORM Navigates Chaotic Waters With Impressive Earnings Alright, TORM's catching my eye here amidst what seems like a global logistical mess. These folks are proving that chaos can indeed be lucrative. Cranking out robust numbers in Q3 2026, they've managed to steer through the murky oil trade waters carved by US-Iran tensions. We're seeing TORM's time charter equivalent...

Continue Reading
Illinois House Democrats Surge with Historic Gaines

Updated Category News Views 79

Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...

Continue Reading
Mesirow's Strategic Advisory on Canworks-Mason Wells Sale

Updated Category News Views 94

A New Chapter for Canworks When companies change hands, it's more than just swapping logos on a building; it's about strategic alignment and market maneuvering. Canworks, a rising star in the direct-to-aluminum-can digital printing arena, is the latest player to shift gears by selling to Mason Wells. The whole deal, spearheaded by Mesirow's ace advisory team, represents a...

Continue Reading
Chord's Zenlytic Move: A Power Play in AI Expansion

Updated Category News Views 120

Chord's Bold Acquisition: Zenlytic Joins the Fold In a gutsy move that’s got folks buzzing, Chord has pulled Zenlytic into its orbit. Announced with a bang on November 3, 2026, this acquisition isn't just some flimsy, seasonal grab. They're doubling down on AI and doubling their revenue while they're at it. Now, brace yourselves: with giants like Verizon, J.Crew,...

Continue Reading
PeptideWorld Paves the Way for Innovative Peptide Education

Updated Category News Views 22

The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Excellence in Craft Beer: 2025 Award Highlights

Updated Category News Views 395

Celebrating the 2025 Industry Award Winners In 2025, the brewing community shines brightly with recognition for notable contributions and innovations. The Brewers Association (BA), a dedicated organization supporting small and independent American craft brewers, is excited to honor several exemplary individuals and groups who have made a significant impact on the craft...

Continue Reading
Berry Global Plans Senior Secured Notes Offering Ahead of Merger

Updated Category News Views 76

Berry Global’s Strategic Offering of Senior Secured Notes In an exciting development, Berry Global Group, Inc. (NYSE:BERY) has outlined plans for the issuance of senior secured notes through its subsidiary, Treasure Escrow Corporation. This move is a crucial step in conjunction with the anticipated merger of Berry's Health, Hygiene and Specialties Global Nonwovens and...

Continue Reading
Newell Brands Earnings Outlook: Key Insights for Investors

Updated Category News Views 175

Understanding Newell Brands Earnings Expectations Newell Brands (NASDAQ: NWL) is preparing for its upcoming quarterly earnings announcement. Investors are eager to see the performance metrics that will shape market sentiments. Analysts predict an earnings per share (EPS) of $0.24, but many are hoping for even better results that will exceed expectations, bringing positive...

Continue Reading
Deep Fission and Endeavour Collaborate on Affordable Nuclear Energy

Updated Category News Views 220

Deep Fission Partners with Endeavour Energy for Innovative Nuclear Solutions Deep Fission Inc., a trailblazer in nuclear power technology, has forged a partnership with Endeavour Energy, LLC, designed to transform the energy landscape. This collaboration focuses on delivering low-cost nuclear power aimed at addressing the energy consumption demands of modern data centers....

Continue Reading
Immunic, Inc. Updates Financial Performance and Milestones

Updated Category News Views 184

Immunic, Inc. Financial Update and Corporate Highlights Immunic, Inc. (NASDAQ: IMUX), a biotechnology company focusing on innovative oral therapies for neurological and gastrointestinal disorders, has shared its financial results for the most recent quarter and announced significant corporate updates. Key Highlights From the Third Quarter The recent financial results...

Continue Reading